Paper40402425
Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions.
Chopko TC and 3 others. Ann Surg Oncol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions. Papers, record 40402425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40402425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Esophageal Neoplasms | Major topic |
| Sentinel Lymph Node | Major topic |
| Sentinel Lymph Node Biopsy | Major topic |
| Humans | |
| Lymph Node Excision | |
| Prognosis | |
| Lymphatic Metastasis | |
| Esophagectomy |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 2 | 19036143 | Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). | BMC Surg | 2008 | https://conductscience.org/library/papers/19036143 | PubMed |
| 3 | 26254683 | Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/26254683 | PubMed |
| 4 | 33891478 | Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33891478 | PubMed |
| 5 | 19392846 | The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma. | Dis Esophagus | 2010 | https://conductscience.org/library/papers/19392846 | PubMed |
| 6 | 14566257 | Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. | J Thorac Cardiovasc Surg | 2003 | https://conductscience.org/library/papers/14566257 | PubMed |
| 7 | 18216546 | The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. | Ann Surg | 2008 | https://conductscience.org/library/papers/18216546 | PubMed |
| 8 | 31188203 | Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis. | Ann Surg | 2020 | https://conductscience.org/library/papers/31188203 | PubMed |
| 9 | 32519142 | Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? | Ann Surg Oncol | 2020 | https://conductscience.org/library/papers/32519142 | PubMed |
| 10 | 30903323 | Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey. | Ann Surg Oncol | 2019 | https://conductscience.org/library/papers/30903323 | PubMed |
| 11 | 35689575 | Two- versus three-field lymphadenectomy for esophageal cancer. A systematic review and meta-analysis of early and late results. | J Surg Oncol | 2022 | https://conductscience.org/library/papers/35689575 | PubMed |
| 12 | 39080133 | The Impact of D2 Versus D1 Lymphadenectomy in Siewert II Gastroesophageal Junction (GEJ) Cancer. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/39080133 | PubMed |
| 13 | 11573045 | Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. | Ann Surg | 2001 | https://conductscience.org/library/papers/11573045 | PubMed |
| 14 | 33551083 | Esophageal Cancer: Tumor-Node-Metastasis Staging. | Radiol Clin North Am | 2021 | https://conductscience.org/library/papers/33551083 | PubMed |
| 15 | 20189259 | Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. | Radiother Oncol | 2010 | https://conductscience.org/library/papers/20189259 | PubMed |
| 16 | 20971285 | Prognostic relevance of skip metastases in esophageal cancer. | Ann Thorac Surg | 2010 | https://conductscience.org/library/papers/20971285 | PubMed |
| 17 | 37015332 | Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2023 | https://conductscience.org/library/papers/37015332 | PubMed |
| 18 | 34544603 | Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis. | Surgery | 2022 | https://conductscience.org/library/papers/34544603 | PubMed |
| 19 | 25548502 | Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25548502 | PubMed |
| 20 | 30119872 | Operative time in esophagectomy: Does it affect outcomes? | Surgery | 2018 | https://conductscience.org/library/papers/30119872 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42731004 | Sentinel Node Navigation Surgery for Upper Gastrointestinal Malignancies: Current Status, Clinical Significance, and Future Perspectives. | Magy Onkol | 2026 | https://conductscience.org/library/papers/42731004 | PubMed |
| 42374006 | Reconsidering the Value of Lymphadenectomy in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Immunotherapy: Insights from a Multicenter Retrospective Study. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42374006 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NODAL | 4838 | PubTator's text mining | https://conductscience.org/library/genes/4838 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40402425
GET https://conductscience.org/api/papers/v1/40402425/references?page=2